Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Multiple Myeloma 11Recurrence 8Lymphoma, Large B-Cell, Diffuse 6Sezary Syndrome 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Leukemia 3Hodgkin Disease 3Waldenstrom Macroglobulinemia 2Neoplasms 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Extranodal NK-T-Cell 2Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Immunoblastic Lymphadenopathy 2Glioma 2Glioblastoma 2Colorectal Neoplasms 2Breast Neoplasms 2Thyroid Neoplasms 1Thyroid Diseases 1Stomach Neoplasms 1Somatostatinoma 1Small Cell Lung Carcinoma 1

Interventions

Temozolomide 7Radiotherapy 3Everolimus 3nimotuzumab 2Erlotinib Hydrochloride 2Cyclophosphamide 2Bevacizumab 2tovorafenib 1ribociclib 1palbociclib 1olutasidenib 1antineoplaston AS 2-1 1antineoplaston A10 1Vinorelbine 1Valproic Acid 1Topotecan 1TIC10 compound 1Radiation 1Proto-Oncogene Proteins c-akt 1Phosphatidylinositol 3-Kinases 1Panobinostat 1Lomustine 1Irinotecan 1Injections 1GDC-0084 1Etoposide 1Drug Therapy 1Doxorubicin 1Diphtheria-Tetanus Vaccine 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Diffuse Intrinsic Pontine Glioma × Panobinostat × Clear all
NCT03632317 2019-08-19

A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas

University of Michigan Rogel Cancer Center

Phase 2 Withdrawn
CNS

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡